Read + Share
Amedeo Smart
Independent Medical Education
Maziarz RT, Bishop MR, Tam CS, Borchmann P, et al. Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma. J Clin Oncol 2025 Nov 18:JCO2500507. doi: 10.1200/JCO-25-00507.PMID: 41252666
Email
LinkedIn
Privacy Policy